(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion ...

Stellantis warns of a hefty $1.7 billion impact from US tariffs in 2025, citing challenges from profit drops, leadership ...

The EU has agreed to a 15% tariff on most of its exports to the US, a steep rate likely to impact European industries. In ...

While some analysts forecasted the tariffs could mean billions in additional industry expenditure, others expect the overall ...

German auto companies embraced greater clarity but warned that even the lower rate of tariffs agreed between Brussels and ...

Thailand’s trade deal with the US faces delay due to ongoing border tensions with Cambodia, with a potential 36% tariff set ...

Though the Trump administration and European Union have agreed to a deal that reduces planned U.S. tariffs, Mexico still ...

Stellantis has outlined the sizeable impact of US tariffs – which apply to imported vehicles and parts – on its business. The company expects tariffs to reduce its earnings by around €1.5bn this year ...

The president’s vision for reshaping global trade is falling into place, but he is embarking on an experiment that economists ...

Pharmaceutical companies are seeking clarification on tariffs imposed under the new US-EU trade agreement . Analysts caution ...

Despite being significantly lower than the 200% rate threatened by Trump, the deal is set to ramp up drug costs by billions.

Tariffs, including the 15% rate for most imports from the EU, would raise consumer prices by 1.8% in the short run, according ...